arrow
C

Camille Locht

University of Lille
H指数:82
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6–17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial

BPZE1(一种鼻内接种的减毒百日咳活疫苗)的免疫原性和安全性评估:在6至17岁健康儿童中与减少破伤风成分的白喉-无细胞百日咳疫苗进行活性对照和安慰剂对照的随机Ⅱb期试验

2026-10-010
OAAI
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation

BPZE1疫苗接种诱导产生与人类鼻粘膜分泌性IgA反应相关的IL-17+和IL-22+ CD4+ T细胞:对致病性百日咳博德特菌定植的影响

2026-04-180
OAAI
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis

活 attenuated 鼻内百日咳疫苗 BPZE1 在英国的有效性、免疫原性和安全性:一项采用毒力性 Bordetella pertussis 的受控人体感染模型进行的随机、安慰剂对照、2b 期试验

2025-12-010
OAAI
Highlights of the 14th International Bordetella Symposium

第十四届国际博德特菌 Symposium 的亮点

MSPHERE
IF3.1
2025-05-160
OA
The heparin-binding hemagglutinin protein of Mycobacterium tuberculosis is a nucleoid-associated protein
2023-12-012
OAAI